Shire
Shire Wins FDA Approval for Motegrity for CIC
Motegrity, a selective serotonin-4 (5-HT4) receptor agonist, works by enhancing colonic peristalsis to increase ...
DECEMBER 20, 2018
FDA Approves Takhzyro for Rare Hereditary Angioedema
Takhzyro is the first monoclonal antibody approved in the United States to prevent attacks of hereditary angioedema ...
AUGUST 27, 2018
ADHD Scripts for Reproductive-Aged Women Rise 344% or More
CDC highlights need for clinicians, patients to understand safety of ADHD medications during pregnancy.
JANUARY 25, 2018
Load more